Abdominal surgery induces long-lasting changes in expression and binding of CTCF with impact on Major Histocompatibility Complex II transcription in circulating human monocytes.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 16 04 2023
accepted: 11 10 2023
medline: 27 10 2023
pubmed: 25 10 2023
entrez: 25 10 2023
Statut: epublish

Résumé

Postoperative immunosuppression has been recognized as an important driver of surgery-related morbidity and mortality. It is characterized by lymphocyte depression and impaired monocyte capability to present foreign antigens to T-cells via Major Histocompatibility Complex, Class II (MHC-II) molecules. In patients with postoperative abdominal sepsis, we previously detected a persisting differential binding of the CCCTC-Binding Factor (CTCF), a superordinate regulator of transcription, inside the MHC-II region with specific impact on human leucocyte antigen (HLA) gene expression. In this prospective exploratory study, we investigated to which extent major surgery affects the MHC-II region of circulating CD14+-monocytes. In non-immunocompromised patients undergoing elective major abdominal surgery, a postoperative loss of monocyte HLA-DR surface receptor density was accompanied by a decline in the transcription levels of the classical MHC-II genes HLA-DRA, HLA-DRB1, HLA-DPA1 and HLA-DPB1. The surgical event decreased the expression of the transcriptional MHC-II regulators CIITA and CTCF and led to a lower CTCF enrichment at an intergenic sequence within the HLA-DR subregion. During the observation period, we found a slow and only incomplete restoration of monocyte HLA-DR surface receptor density as well as a partial recovery of CIITA, HLA-DRA and HLA-DRB1 expression. In contrast, transcription of HLA-DPA1, HLA-DPB1, CTCF and binding of CTCF within the MHC-II remained altered. In circulating monocytes, major surgery does not globally affect MHC-II transcription but rather induces specific changes in the expression of selected HLA genes, followed by differential recovery patterns and accompanied by a prolonged reduction of CTCF expression and binding within the MHC-II region. Our results hint toward a long-lasting impact of a major surgical intervention on monocyte functionality, possibly mediated by epigenetic changes that endure the life span of the individual cell.

Sections du résumé

BACKGROUND
Postoperative immunosuppression has been recognized as an important driver of surgery-related morbidity and mortality. It is characterized by lymphocyte depression and impaired monocyte capability to present foreign antigens to T-cells via Major Histocompatibility Complex, Class II (MHC-II) molecules. In patients with postoperative abdominal sepsis, we previously detected a persisting differential binding of the CCCTC-Binding Factor (CTCF), a superordinate regulator of transcription, inside the MHC-II region with specific impact on human leucocyte antigen (HLA) gene expression. In this prospective exploratory study, we investigated to which extent major surgery affects the MHC-II region of circulating CD14+-monocytes.
RESULTS
In non-immunocompromised patients undergoing elective major abdominal surgery, a postoperative loss of monocyte HLA-DR surface receptor density was accompanied by a decline in the transcription levels of the classical MHC-II genes HLA-DRA, HLA-DRB1, HLA-DPA1 and HLA-DPB1. The surgical event decreased the expression of the transcriptional MHC-II regulators CIITA and CTCF and led to a lower CTCF enrichment at an intergenic sequence within the HLA-DR subregion. During the observation period, we found a slow and only incomplete restoration of monocyte HLA-DR surface receptor density as well as a partial recovery of CIITA, HLA-DRA and HLA-DRB1 expression. In contrast, transcription of HLA-DPA1, HLA-DPB1, CTCF and binding of CTCF within the MHC-II remained altered.
CONCLUSION
In circulating monocytes, major surgery does not globally affect MHC-II transcription but rather induces specific changes in the expression of selected HLA genes, followed by differential recovery patterns and accompanied by a prolonged reduction of CTCF expression and binding within the MHC-II region. Our results hint toward a long-lasting impact of a major surgical intervention on monocyte functionality, possibly mediated by epigenetic changes that endure the life span of the individual cell.

Identifiants

pubmed: 37878653
doi: 10.1371/journal.pone.0293347
pii: PONE-D-23-11182
pmc: PMC10599505
doi:

Substances chimiques

CCCTC-Binding Factor 0
HLA-DR alpha-Chains 0
HLA-DRB1 Chains 0
Histocompatibility Antigens Class II 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0293347

Informations de copyright

Copyright: © 2023 Siegler et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Pediatr Surg Int. 2006 Apr;22(4):330-4
pubmed: 16496161
Curr Opin Immunol. 2011 Feb;23(1):81-7
pubmed: 20970972
J Immunol. 2011 Oct 15;187(8):4236-44
pubmed: 21911605
Front Immunol. 2022 Oct 27;13:1031216
pubmed: 36389839
Mol Cell Biol. 2010 Sep;30(17):4211-23
pubmed: 20584980
J Innate Immun. 2010;2(3):204-15
pubmed: 20375558
J Am Coll Surg. 2019 Aug;229(2):200-209
pubmed: 30905855
Surgeon. 2011 Feb;9(1):38-43
pubmed: 21195330
J Hum Genet. 2009 Jan;54(1):15-39
pubmed: 19158813
Hepatogastroenterology. 2004 Nov-Dec;51(60):1595-9
pubmed: 15532785
PLoS One. 2012;7(7):e41374
pubmed: 22829947
Crit Care. 2020 Mar 20;24(1):110
pubmed: 32192532
PLoS One. 2018 Sep 13;13(9):e0204168
pubmed: 30212590
Sci Transl Med. 2014 Dec 3;6(265):265sr6
pubmed: 25473038
J Biol Chem. 2006 Jul 7;281(27):18435-43
pubmed: 16675454
Cell. 2009 Jun 26;137(7):1194-211
pubmed: 19563753
World J Surg. 1999 Jan;23(1):18-22
pubmed: 9841758
Curr Opin Anaesthesiol. 2016 Jun;29(3):376-83
pubmed: 26963469
Cell. 2002 Apr;109 Suppl:S21-33
pubmed: 11983150
J Exp Med. 2008 Apr 14;205(4):785-98
pubmed: 18347100
Vascul Pharmacol. 2015 Aug;71:31-6
pubmed: 25869514
Front Surg. 2015 Sep 03;2:43
pubmed: 26389122
Cell Rep. 2015 Aug 18;12(7):1184-95
pubmed: 26257180
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Blood. 2000 Jul 1;96(1):218-23
pubmed: 10891454
Clin Sci (Lond). 1990 Aug;79(2):161-5
pubmed: 2167805
J Lab Clin Med. 1996 Dec;128(6):594-600
pubmed: 8960643
Nature. 1995 Jun 29;375(6534):802-6
pubmed: 7596415
Crit Care. 2010;14(2):R61
pubmed: 20385017
PLoS One. 2021 May 3;16(5):e0250818
pubmed: 33939725
J Pediatr Intensive Care. 2020 Sep 11;10(4):248-255
pubmed: 34745697
Surgery. 1994 Apr;115(4):424-8
pubmed: 8165532
J Exp Med. 2020 Feb 3;217(2):
pubmed: 31753848
Ann Surg. 2016 Jul;264(1):73-80
pubmed: 27275778
Transpl Immunol. 2018 Dec;51:6-11
pubmed: 30081187
Trends Genet. 2001 Sep;17(9):520-7
pubmed: 11525835
J Exp Med. 2017 Jul 3;214(7):1913-1923
pubmed: 28606987
Genome Biol. 2017 Apr 27;18(1):76
pubmed: 28449694

Auteurs

Benedikt Hermann Siegler (BH)

Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg University, Heidelberg, Baden-Württemberg, Germany.

Jan Niklas Thon (JN)

Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg University, Heidelberg, Baden-Württemberg, Germany.

Marc Altvater (M)

Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg University, Heidelberg, Baden-Württemberg, Germany.

Judith Schenz (J)

Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg University, Heidelberg, Baden-Württemberg, Germany.

Jan Larmann (J)

Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg University, Heidelberg, Baden-Württemberg, Germany.

Markus Alexander Weigand (MA)

Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg University, Heidelberg, Baden-Württemberg, Germany.

Sebastian Weiterer (S)

Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg University, Heidelberg, Baden-Württemberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH